PROKIDNEY CORP. - Ordinary Shares (PROK)

Historical Holders from Q2 2022 to Q3 2025

Type / Class
Equity / Ordinary Shares
Symbol
PROK on Nasdaq
Underlying class
Class A Ordinary Shares
Shares outstanding
129,821,091
Price per share
$2.42
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
1,000,917
Holdings value
$2,422,308
% of all portfolios
0%
Share change
-33,689,498
Value change
-$19,991,590
Average buys %
0%
Average sells %
-0%
Number of holders
4
Price from insider filings
$2.37
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PROKIDNEY CORP. - Ordinary Shares (PROK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Tolerantia, LLC 36% -3.9% $93,004,165 -$3,326,877 106,901,339 -3.5% Tolerantia, LLC 03 Jun 2025
MORGAN STANLEY 4.4% -42% $4,969,551 -$3,781,713 5,712,128 -43% Morgan Stanley 30 Jun 2025
BlackRock, Inc. 1.4% $1,535,204 1,764,602 BlackRock, Inc. 30 Jun 2025
As of 30 Sep 2025, PROKIDNEY CORP. - Ordinary Shares (PROK) has 4 institutional shareholders filing 13F forms. They hold 1,000,917 shares of 129,821,091 outstanding shares (0.77%) .

Institutional Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1,000,917 $2,422,308 -$19,991,590 $2.42 4
2025 Q2 34,704,785 $20,548,206 -$8,230,895 $0.5921 50
2025 Q1 47,997,221 $42,032,741 -$2,665,010 $0.8762 68
2024 Q4 50,919,833 $86,053,473 +$2,729,860 $1.69 72
2024 Q3 49,144,737 $94,328,145 +$11,886,325 $1.92 73
2024 Q2 40,154,003 $98,780,385 +$11,002,071 $2.46 67
2024 Q1 10,850,740 $17,857,140 -$500,485 $1.64 12
2023 Q4 40,601 $72,270 -$45,253 $1.78 2
2023 Q3 40,408,893 $185,072,309 +$2,224,071 $4.58 63
2023 Q2 30,122,870 $337,087,045 +$57,804,131 $11.19 54
2023 Q1 34,565,347 $391,195,593 +$35,470,839 $11.32 36
2022 Q4 31,432,133 $215,642,663 +$14,576,163 $6.86 26
2022 Q3 16,024,717 $144,382,000 +$137,048,480 $9.01 15
2022 Q2 736,968 $7,334,000 +$7,334,011 $9.95 1